Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1198
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mahasen Juaton, Lynette Cussack | - |
dc.contributor.author | Tim Schultz | - |
dc.date.accessioned | 2022-06-06T07:59:14Z | - |
dc.date.available | 2022-06-06T07:59:14Z | - |
dc.date.issued | 2020-02-12 | - |
dc.identifier.issn | 1447‑4328 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1198 | - |
dc.description | Continually returning once every four weeks to an out-patient department to complete an intravenous infusion can be taxing for chronic disease patients. In Australia, acute care patients may be offered hospital in the home service. In-home services are delivered by highly qualified, trained nurses following the infusion protocols similar to that of the hospital. However, this service is not yet offered for chronic disease patients, such as those with relapsing remitting multiple sclerosis. | en_US |
dc.description.abstract | This study’s objective was to understand the experiences and perspectives of people with multiple sclerosis who received infusions of natalizumab at home instead of the tertiary hospital day unit. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Australian Nursing & Midwifery Federation | en_US |
dc.subject | hospital infusion | en_US |
dc.subject | home infusion | en_US |
dc.subject | patientcentred | en_US |
dc.title | Patients’ experiences of natalizumab treatment in a home environment: a qualitative study | en_US |
dc.type | Article | en_US |
Appears in Collections: | 2. Australian Journal of Advanced Nursing |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.